在非典型的血溶性尿素性综合征中抗B因子抗体
Priyanka Khandelwal1, Shreesha Nambiar1, Rahul Saini1
1Division of Nephrology, Department of Pediatrics, ICMR Center for Advanced Research in Nephrology, All India Institute of Medical Sciences, New Delhi, India.
Pediatric nephrology (Berlin, Germany)
|January 22, 2024
概括
对抗B因子 (FB) 抗体在9.7%的非典型血清性尿素综合征 (aHUS) 儿童中被发现,与疾病严重程度相关. 这些抗体也存在于C3G/IC-MPGN患者中,但标位低于aHUS.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
- 儿科 儿科 儿科
背景情况:
- 在30%-40%的患者中,非典型的血溶性尿素性综合征 (aHUS) 的原因尚不清楚.
- 抗B因子 (FB) 抗体已在C3型血小板病 (C3G) 和免疫复杂膜增殖性血小板炎 (IC-MPGN) 中被发现,但以前在aHUS中没有发现.
研究的目的:
- 调查抗FB抗体在儿科aHUS中的流行率和重要性.
- 为了将aHUS中的抗FB抗体水平与C3G和IC-MPGN.中的抗体水平进行比较.
主要方法:
- 使用ELISA和西方血型测试对儿科aHUS,C3G和IC-MPGN队列进行抗FBIgG抗体的查.
- 与103名健康献血者抗体水平的比较以及与临床参数的相关性.
主要成果:
- 在9.7%的aHUS患者中检测到抗FB抗体,包括那些与抗H因子 (FH) 相关且病因不明的患者.
- 与C3G/IC-MPGN患者相比,aHUS患者的抗体标位较高,并且与疾病严重程度 (血红蛋白,血小板) 相相关.
- 在血交换后,抗FB抗体水平下降,在复发期间增加,这表明在疾病活动中发挥了作用.
结论:
- 抗FB抗体存在于儿科aHUS,C3G和IC-MPGN患者的一个子集中,aHUS的患病率和标位更高.
- 在aHUS中抗FB抗体的诊断和治疗含义需要进一步调查.
- 这项研究强调了印度儿童患有HUS的自身抗体生成和共存风险因素的趋势.
相关概念视频
Blood Typing
1.2K
Understanding an individual's blood group is a critical component of transfusion medicine. It ensures compatibility in blood transfusions, organ transplants, and even during pregnancy. Determining these blood groups involves the ABO and Rh blood typing systems, utilizing specific antigens and corresponding anti-sera to identify an individual's blood type.
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target...
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target...
1.2K
Blood Transfusion and Agglutination
10.8K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
10.8K
Rh Blood Group
1.5K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
1.5K


